Are aTXN2 polyQ intermediate repeats a modifier of ALS survival?
ATXN2 polyQ intermediate-length repeat is a modifier of ALS survival. Disease-modifying therapies targeted to ATXN2 represent a promising therapeutic approach for ALS.
Serum cotinine may be a better method of quantifying risks from cigarette use in epidemiological studies.